- Oxea increased capacity for specialty esters by 20% at its Amsterdam plant.
- The investment was in the single-figure million Euro range.
- Products include Oxsoft TOTM and DOTP, phthalate-free plasticizers.
- The expansion supports medical device and flooring producers.
Capacity Increase
Oxea has successfully increased its capacity for specialty esters by 20% at its Amsterdam Esters Plant (AEP). This expansion was achieved through an investment in the single-figure million Euro range, aimed at implementing several optimization measures.
Product Range
At AEP, Oxea produces several phthalate-free plasticizers, including Oxsoft TOTM (trioctyl trimellitate) and DOTP (dioctyl terephthalate), marketed under the brand name Oxsoft GPO. These products are designed to serve as alternatives to conventional plasticizers like dioctyl phthalate (DOP) and diisononyl phthalate (DINP).
Market Demand
The capacity upgrade is particularly beneficial for producers of medical devices and flooring, who are increasingly seeking phthalate-free alternatives. The shift in market demand was highlighted by a leading flooring company's recent decision to switch to phthalate-free products and the main European DOP producer's announcement to discontinue DOP production.
Strategic Vision
Oxea's capacity expansion aligns with the company's strategic vision to meet the industry's evolving requirements. The increasing demand for phthalate-free plasticizers underscores the necessity for continuous investments and initiatives to ensure sufficient and reliable supplies of specialty esters.
